• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Nat Commun . Characterization of two non-competing antibodies to influenza H3N2 hemagglutinin stem reveals its evolving antigenicity

tetano

Editor, Senior Moderator
Nat Commun


. 2025 Nov 26;16(1):10557.
doi: 10.1038/s41467-025-65595-1. Characterization of two non-competing antibodies to influenza H3N2 hemagglutinin stem reveals its evolving antigenicity

Akshita B Gopal[SUP] #[/SUP][SUP] 1 [/SUP], Huibin Lv[SUP] #[/SUP][SUP] 2 3 [/SUP], Tossapol Pholcharee[SUP] 1 [/SUP], Wenhao O Ouyang[SUP] 1 [/SUP], Qi Wen Teo[SUP] 1 4 [/SUP], Yasha Luo[SUP] 5 [/SUP], Yun Sang Tang[SUP] 6 7 [/SUP], Mingyong Luo[SUP] 5 [/SUP], Chris K P Mok[SUP] 6 7 8 9 [/SUP], Nicholas C Wu[SUP] 10 11 12 13 [/SUP]



Affiliations
Abstract

The conserved stem domain of influenza hemagglutinin (HA), which is classified into group 1 and group 2, is a target of broadly neutralizing antibodies. While many group 1 HA stem antibodies have been described, much less is known about group 2 HA stem antibodies. This study structurally characterizes two group 2 HA stem antibodies, 2F02 and AG2-G02, targeting the central stem epitope and the lower stem epitope, respectively. Unlike prototypic antibodies to group 2 HA stem, 2F02 and AG2-G02 do not compete for binding. Both antibodies offer protection in a female mouse model via neutralization activity and Fc-mediated effector functions. We further demonstrate that the natural evolution of HA2 position 32 restricts the binding of AG2-G02 to recent human H3N2 HAs and influences the binding of human plasma samples. Overall, these findings advance our understanding of the antigenicity of HA stem, which has important implications for the development of broadly protective influenza vaccines.


 
Back
Top